GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify"><strong>LA JOLLA, CA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- </strong>GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that <a...